Retinitis Pigmentosa Market to Grow Rapidly at a CAGR of 16.8% by 2034 | DelveInsight

The retinitis pigmentosa market is propelled forward by advancements in gene therapy and innovative treatment modalities, offering promising prospects for slowing down the progression of this degenerative eye disease. Additionally, increasing research investments, growing awareness, and…